COST-MINIMIZATION ANALYSIS (CMA) OF CANAGLIFLOZIN COMPARED TO GLIMEPIRIDE AND SITAGLIPTIN AS DUAL THERAPY IN COMBINATION WITH METFORMIN

被引：0
|
作者：
Ravasio, R. [1 ]
Pisarra, P. [2 ]
Comaschi, M. [3 ]
机构：
[1] Hlth Publishing & Serv, Milan, Italy
[2] Janssen Italy, Cologno Monzese, MI, Italy
[3] GVM Care & Res, ICLAS, Diabetol, Endocrinol,Med Interna, Genoa, Italy
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2111
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB72
引用
收藏
页码：A610 / A610
页数：1
相关论文
共 50 条
  • [1] Economic evaluation of canagliflozin versus glimepiride and sitagliptin in dual therapy with metformin for the treatment of type 2 diabetes in Italy
    Ravasio, Roberto
    Pisarra, Patrizia
    Porzio, Roberto
    Comaschi, Marco
    GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT, 2016, 3 (02) : 92 - 101
  • [2] Achievement of weight loss with canagliflozin, sitagliptin and glimepiride in combination with metformin or metformin plus sulfonylurea in patients with Type 2 diabetes
    Stein, L.
    Thompson, G.
    Diels, J.
    Thilakarathne, P.
    Girod, I.
    DIABETIC MEDICINE, 2014, 31 : 145 - 145
  • [3] Cost-minimization analysis for the treatment of the hyperthyreosis: Strumaresection compared to radioiodine treatment
    Dietlin, M
    Geckle, L
    Overbeck, T
    Moka, D
    Bausch, V
    Troche, CJ
    Lauterbach, K
    Schicha, H
    NUKLEARMEDIZIN, 1997, 36 (05) : 150 - 156
  • [4] A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of skin and skin-structure infections
    Turco, Neil
    Kane-Gill, Sandra
    D'Amico, Frank
    Oleksiuk, Louise-Marie
    Pickering, Aaron
    PHARMACOTHERAPY, 2017, 37 (12): : E200 - E200
  • [5] Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease
    Castaman, Giancarlo
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2016, 17 (02) : 59 - 65
  • [6] THE SGLT2 INHIBITOR CANAGLIFLOZIN SHOWN TO BE SUPERIOR COMPARED WITH GLIMEPIRIDE AS ADD ON THERAPY TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2016, 18 (09): : 949 - 949
  • [7] Pediatric Tele-Home Care Compared to Usual Care: Cost-Minimization Analysis
    Adroher Mas, Cristina
    Esposito Catala, Candela
    Batlle Boada, Astrid
    Casadevall Llandrich, Ricard
    Millet Elizalde, Marta
    Garcia Garcia, Juan Jose
    del Castillo Rey, Manel
    Garcia Cuyas, Francesc
    Pons Serra, Miquel
    Lopez Segui, Francesc
    JMIR PEDIATRICS AND PARENTING, 2022, 5 (01):
  • [8] A cost-minimization analysis of first intention laparoscopic compared to open right hemicolectomy for colon cancer
    Widdison, Adam L.
    Barns, Victoria
    Prescott, Oliver
    Pollard, Adam
    ANNALS OF MEDICINE AND SURGERY, 2016, 5 : 23 - 28
  • [9] A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of acute bacterial skin and skin-structure infections
    Turco, Neil J.
    Kane-Gill, Sandra L.
    Hernandez, Inmaculada
    Oleksiuk, Louise-Marie
    D'Amico, Frank
    Pickering, Aaron J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (04) : 319 - 325
  • [10] A COST-MINIMIZATION ANALYSIS FOR TYPE 2 DIABETES WITH INSULIN GLARGINE COMPARED TO INSULIN DETERMIR IN A BASAL SUPPORTED ORAL THERAPY IN CHINA
    Dong, H.
    VALUE IN HEALTH, 2010, 13 (03) : A60 - A61
12345